Seed financing announcement for new ICR and Oxford spinout company Kodiform Therapeutics 11 Jun 2024 Kodiform Therapeutics, a new joint spin-out company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises. Find out more Show/Hide
New AI collaboration could advance precision therapy in breast cancer 09 Feb 2024 A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer patients who could benefit from it. Find out more Show/Hide
ICR amongst top UK universities for industry and academic partnerships and public engagement 24 Oct 2023 The ICR has ranked as one of the UK's best higher education institutions at engaging with industry, academic partners and the wider public, in the Government's latest Knowledge Exchange Framework (KEF). Find out more Show/Hide
New MedTech firm expands liquid biopsy research at The London Cancer Hub’s Innovation Gateway 02 Oct 2023
ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs 22 Sep 2023